BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18425369)

  • 1. PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.
    Hennenlotter J; Ohneseit PA; Simon P; Merseburger AS; Serth J; Kuehs U; Kramer M; Hartmann JT; Stenzl A; Kuczyk MA
    Oncol Rep; 2008 May; 19(5):1141-7. PubMed ID: 18425369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
    Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
    Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma.
    Amend B; Hennenlotter J; Scharpf M; Kruck S; Kuehs U; Senger E; Merseburger AS; Kuczyk MA; Sievert KD; Stenzl A; Bedke J
    World J Urol; 2012 Jun; 30(3):353-9. PubMed ID: 21822918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions.
    Merseburger AS; Hennenlotter J; Simon P; Müller CC; Kühs U; Knüchel-Clarke R; Moul JW; Stenzl A; Kuczyk MA
    Oncol Rep; 2006 Jul; 16(1):79-83. PubMed ID: 16786126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
    Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G
    Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
    Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
    Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression.
    Schöndorf T; Hoopmann M; Eversheim B; Valter MM; Becker M; Wappenschmidt B; Göhring UJ; Kübler T; Schmutzler RK; Schäfer R
    Oncol Rep; 2003; 10(6):1717-22. PubMed ID: 14534684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB.
    Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L
    Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.
    Kalogirou C; Schäfer D; Krebs M; Kurz F; Schneider A; Riedmiller H; Kneitz B; Vergho D
    Urol Int; 2016; 96(1):106-15. PubMed ID: 26496641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma.
    He L; Fan C; Gillis A; Feng X; Sanatani M; Hotte S; Kapoor A; Tang D
    Biochim Biophys Acta; 2007 Oct; 1772(10):1134-42. PubMed ID: 17681738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN, pAKT, and pmTOR expression and subcellular distribution in primary renal cell carcinomas and their metastases.
    Hager M; Haufe H; Lusuardi L; Schmeller N; Kolbitsch C
    Cancer Invest; 2011 Aug; 29(7):427-38. PubMed ID: 21696297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study.
    Liu Z; Fu Q; Lv J; Wang F; Ding K
    J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression.
    Kruck S; Bedke J; Hennenlotter J; Ohneseit PA; Kuehs U; Senger E; Sievert KD; Stenzl A
    Oncol Rep; 2010 Jan; 23(1):159-63. PubMed ID: 19956876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.
    Wang H; Zhang P; Lin C; Yu Q; Wu J; Wang L; Cui Y; Wang K; Gao Z; Li H
    PLoS One; 2015; 10(2):e114250. PubMed ID: 25714556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.